Lisa M. Ferri

Partner at Mayer Brown LLP

Lisa M. Ferri

Lisa M. Ferri

Partner at Mayer Brown LLP

Biography

Lisa M. Ferri is a partner in New York and co-lead of Mayer Brown’s Intellectual Property practice. She serves as lead trial and appellate counsel on behalf of high-profile companies in the pharmaceutical, biotechnology and medical device industries. Lisa is a seasoned and versatile litigator having tried high-stakes cases in federal courts across the country and the International Trade Commission, argued before the Patent Trial and Appeal Board (PTAB), and the Federal Circuit Court of Appeals. She has significant expertise guiding companies through patent challenges under the Hatch-Waxman Act and Biologics Price Competition and Innovation Act (BPCIA).

Lisa has been recognized by clients and peers as a leading lawyer in intellectual property. She was named one of the "Top 250 Women in IP" by Managing Intellectual Property each year since the list’s inception in 2013 and was named a leading lawyer in Who’s Who Legal: Patents 2016 and 2017. Lisa was recognized by IAM Patent 1000 as "spectacular . . . [she] demonstrates a lot of powerful qualities as a patent litigator" and is "extremely persuasive." She was named a "Life Sciences Star" and an "IP Star" by the Legal Media Group, which noted that "Lisa is professional, intelligent, people savvy, tough when need be, and has a great command of the applicable law." Lisa was nominated in 2014 as "Hatch-Waxman Litigator of the Year" by the LMG Life Sciences Awards. In addition, she has been recognized in the area of patent litigation by the Legal 500. Her recent victory at the Federal Circuit Court of Appeals in Biogen IDEC, Inc. and Genentech v. GlaxoSmithKline, which involved the monoclonal antibody therapy Arzerra®, was shortlisted for "Patent Impact Case of the Year" by the LMG Life Sciences Awards.

Lisa's life sciences practice spans a broad range of therapeutic areas and technologies—from pharmaceuticals and biologics for the treatment of HIV/AIDS, cancer, hepatitis, influenza, auto-immunities, anemia, emesis and BPH, to drug delivery systems, research tools, recombinant DNA, RNAi and a variety of medical devices. Her pharmaceutical practice focuses on representing innovator companies in cases brought pursuant to the Hatch-Waxman Act. She has successfully defended a number of key blockbuster drugs. Following enactment of the AIA, Lisa handled one of the first co-pending inter partes reviews and district court litigations relating to the Orange Book listed drug Lexiva® -- which was the first "lead compound" IPR before the PTAB as well. Lisa also concentrates on patent litigation dealing with large molecule biologics products including a series of antibody litigations involving the well-known "Cabilly" patent portfolio.

Lisa is an adjunct professor at Fordham University School of Law where she teaches Patent Litigation.

Lisa serves as co-chair of the firm's global Women's Leadership Committee.

Overview
RelSci Relationships

1270

Number of Boards

1

Contact Data
Trying to get in touch with Lisa M. Ferri? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Lisa M. Ferri likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman at Mayer Brown LLP

Relationship likelihood: Strong

Senior Partner at Mayer Brown LLP

Relationship likelihood: Strong

Co-Chair, Global Intellectual Property Practice Group at Mayer Brown LLP

Relationship likelihood: Strong

Co-Chair, Consumer Class Action Practice Group at Mayer Brown LLP

Relationship likelihood: Strong

Co-Chair, Consumer Litigation & Class Actions Practice at Mayer Brown LLP

Relationship likelihood: Strong

Senior Partner, London at Mayer Brown LLP

Relationship likelihood: Strong

Partner at Mayer Brown LLP

Relationship likelihood: Strong

Partner at Mayer Brown LLP

Relationship likelihood: Strong

Partner at Mayer Brown LLP

Relationship likelihood: Strong

Partner at Mayer Brown LLP

Relationship likelihood: Strong

Paths to Lisa M. Ferri
Potential Connections via
Relationship Science
You
Lisa M. Ferri
Partner at Mayer Brown LLP
Career History
Partner
Current

Mayer Brown LLP provides legal services in areas of banking and finance; corporate and securities; litigation and dispute resolution; antitrust and competition; U.S. Supreme Court and appellate matters; employment and benefits; environmental; financial services regulatory and enforcement; government and global trade; intellectual property; real estate; tax; restructuring, bankruptcy and insolvency; and wealth management. The company was founded in 1881 and is headquartered in Chicago, IL.

Transactions
Details Hidden

Bristol-Myers Squibb Company purchases Celgene Corp.

Other Affiliations

Lisa M. Ferri is affiliated with Mayer Brown LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lisa M. Ferri. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lisa M. Ferri's profile does not indicate a business or promotional relationship of any kind between RelSci and Lisa M. Ferri.